Cited by 180Platelet Disorders and TreatmentsCell Adhesion Molecules ResearchBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans

Open access

Carneiro, Ana Marin D., Cook, Edwin H., Murphy, Dennis L., Blakely, Randy D.·2008·Journal of Clinical Investigation

DOI 10.1172/jci33374PMC PMC2260909

Open this paper in CoChat — free account

Abstract

The essential contribution of the antidepressant-sensitive serotonin (5-HT) transporter SERT (which is encoded by the SLC6A4 gene) to platelet 5-HT stores suggests an important role of this transporter in platelet function. Here, using SERT-deficient mice, we have established a role for constitutive SERT expression in efficient ADP- and thrombin-triggered platelet aggregation. Additionally, using pharmacological blockers of SERT and the vesicular monoamine transporter (VMAT), we have identified a role for ongoing 5-HT release and SERT activity in efficient human platelet aggregation. We have also demonstrated that fibrinogen, an activator of integrin alphaIIbbeta3, enhances SERT activity in human platelets and that integrin alphaIIbbeta3 interacts directly with the C terminus of SERT. Consistent with these findings, knockout mice lacking integrin beta3 displayed diminished platelet SERT activity. Conversely, HEK293 cells engineered to express human SERT and an activated form of integrin beta3 exhibited enhanced SERT function that coincided with elevated SERT surface expression. Our results support an unsuspected role of alphaIIbbeta3/SERT associations as well as alphaIIbbeta3 activation in control of SERT activity in vivo that may have broad implications for hyperserotonemia, cardiovascular disorders, and autism.

Integrity signals

Registry

Crossref · 10.1172/jci33374

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient Mic
Bengel, D., Murphy, D. L., Andrews, A. M., Wichems, C. H., Feltner, D. E., Heils, A., Mößner, R., Westphal, H., & Lesch, K. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.649 · Cited by 719
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
Trip, M. D., Cats, V. M., van Capelle, F. J. L., & Vreeken, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222201 · Cited by 614
Review article: serotonin receptors and transporters — roles in normal and abnormal gastrointestinal motility
Gershon, M. D. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02180.x · Cited by 521
Integrin signaling to the actin cytoskeleton
DeMali, K. A., Wennerberg, K., & Burridge, K. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00109-1 · Cited by 511
Serotonylation of small GTPases is a signal transduction pathway that triggers platelet α-granule release
Walther, D. J., Peter, J.-U., Winter, S., Höltje, M., Paulmann, N., Grohmann, M., Vowinckel, J., Alamo-Bethencourt, V., Wilhelm, C. S., Ahnert-Hilger, G., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)01014-6 · Cited by 475
Phosphorylation and Sequestration of Serotonin Transporters Differentially Modulated by Psychostimulants
Ramamoorthy, S., & Blakely, R. (1999) · Science · doi:10.1126/science.285.5428.763 · Cited by 392
Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse
Chavis, P., & Westbrook, G. L. (2001) · Nature · doi:10.1038/35077101 · Cited by 332
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene
Eddahibi, S., Hanoun, N., Lanfumey, L., Lesch, K., Raffestin, B., Hamon, M., & Adnot, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8678 · Cited by 330
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype
Ozaki, N., Goldman, D. A., Kaye, W. H., Plotnicov, K. H., Greenberg, B. D., Lappalainen, J., Rudnick, G., & Murphy, D. L. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001365 · Cited by 275
Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies
Qian, Y., Melikian, H. E., Rye, D., Levey, A. I., & Blakely, R. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01261.1995 · Cited by 256
Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction
Sauer, W. H., Berlin, J. A., & Kimmel, S. E. (2003) · Circulation · doi:10.1161/01.cir.0000079172.43229.cd · Cited by 247
Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A
Bauman, A. L., Apparsundaram, S., Ramamoorthy, S., Wadzinski, B. E., Vaughan, R. A., & Blakely, R. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07571.2000 · Cited by 235
P38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process
Zhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228
Self-citation
A Role for p38 Mitogen-Activated Protein Kinase in the Regulation of the Serotonin Transporter: Evidence for Distinct Cellular Mechanisms Involved in Transporter Surface Expression
Samuvel, D. J., Jayanthi, L. D., Bhat, N. R., & Ramamoorthy, S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3754-04.2005 · Cited by 215
Platelet Reactivity in Depressed Patients Treated With Paroxetine
Musselman, D. L., Marzec, U. M., Manatunga, A. K., Penna, S., Reemsnyder, A., Knight, B. T., Барон, А. В., Hanson, S. R., & Nemeroff, C. B. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.875 · Cited by 203
The influence of selective serotonin reuptake inhibitors on human platelet serotonin
Pittendreigh, C., Solomons, K., & Maurer‐Spurej, E. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-05-0330 · Cited by 199
Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins
Blakely, R., Ramamoorthy, S., Schroeter, S., Qian, Y., Apparsundaram, S., Galli, A., & DeFelice, L. J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00124-3 · Cited by 193
Adenosine Receptor, Protein Kinase G, and p38 Mitogen-Activated Protein Kinase-Dependent Up-Regulation of Serotonin Transporters Involves Both Transporter Trafficking and Activation
Zhu, C.-B., Hewlett, W. A., Feoktistov, I., Biaggioni, I., & Blakely, R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1462 · Cited by 168
Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes
Liu, Q., & Hofmann, P. A. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01050.2003 · Cited by 161
Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels
Coutinho, A. M., Sousa, I., Martins, M., Correia, C., Morgadinho, T., Bento, C., Marques, C., Ataíde, A., Miguel, T. S., Moore, J. H., et al. (2007) · Human Genetics · doi:10.1007/s00439-006-0301-3 · Cited by 153
Serotonin Transporter and Seasonal Variation in Blood Serotonin in Families with Obsessive-Compulsive Disorder
Hanna, G. L. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00097-3 · Cited by 151
β3 Tyrosine Phosphorylation in αIIbβ3 (Platelet Membrane GP IIb-IIIa) Outside-in Integrin Signaling
Nannizzi‐Alaimo, L., Prasad, K. S. S., & Phillips, D. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616222 · Cited by 135
The PlA2 polymorphism of integrin β3 enhances outside-in signaling and adhesive functions
Vijayan, K. V., Goldschmidt‐Clermont, P. J., Roos, C. M., & Bray, P. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6982 · Cited by 135
Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction
Nakatani, D., Sato, H., Sakata, Y., Shiotani, I., Kinjo, K., Mizuno, H., Shimizu, M., Ito, H., Koretsune, Y., Hirayama, A., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.03.062 · Cited by 134
Depression and cardiovascular comorbidity
Glassman, A. H. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.1/ahglassman · Cited by 127
Evidence for Biphasic Effects of Protein Kinase C on Serotonin Transporter Function, Endocytosis, and Phosphorylation
Jayanthi, L. D., Samuvel, D. J., Blakely, R. D., & Ramamoorthy, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009555 · Cited by 123
Ligand bridging mediates integrin alpha IIb beta 3 (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions.
Gawaz, M., Loftus, J. C., Bajt, M. L., Frojmovic, M. M., Plow, E. F., & Ginsberg, M. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115412 · Cited by 121
Stored human platelets retain full aggregation potential in response to pairs of aggregating agents
DiMinno, G., Silver, M., & Murphy, S. (1982) · Blood · doi:10.1182/blood.v59.3.563.563 · Cited by 118
Transglutaminase-dependent RhoA Activation and Depletion by Serotonin in Vascular Smooth Muscle Cells
Guilluy, C., Rolli‐Derkinderen, M., Tharaux, P., Melino, G., Pacaud, P., & Loirand, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604195200 · Cited by 117
Serotonin-, Protein Kinase C-, and Hic-5-associated Redistribution of the Platelet Serotonin Transporter
Carneiro, A. M. D., & Blakely, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603877200 · Cited by 107
Phosphorylation of Threonine Residue 276 Is Required for Acute Regulation of Serotonin Transporter by Cyclic GMP
Ramamoorthy, S., Samuvel, D. J., Buck, E. R., Rudnick, G., & Jayanthi, L. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611353200 · Cited by 100
Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility
Weiss, L. A., Kosova, G., Delahanty, R., Jiang, L., Cook, E. H., Ober, C., & Sutcliffe, J. S. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201644 · Cited by 92
A Role for Protein Phosphatase-2A in p38 Mitogen-activated Protein Kinase-mediated Regulation of the c-Jun NH2-terminal Kinase Pathway in Human Neutrophils
Briones, N. J., Malcolm, K. C., Nick, J. A., & Worthen, G. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204455200 · Cited by 89
Pharmacologic Treatment of Depression in Patients With Heart Disease
Roose, S. P., & Miyazaki, M. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000163455.43226.bf · Cited by 76
Selective Serotonin Reuptake Inhibitors Yield Additional Antiplatelet Protection in Patients with Congestive Heart Failure Treated with Antecedent Aspirin
Serebruany, V. L., Glassman, A. H., Malinin, A., Atar, D., Sane, D. C., Oshrine, B. R., Ferguson, J. J., & O’Connor, C. M. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00005-9 · Cited by 74
Proximal, selective, and dynamic interactions between integrin αIIbβ3 and protein tyrosine kinases in living cells
de Virgilio, M., Kiosses, W. B., & Shattil, S. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200402064 · Cited by 70
An assessment of platelet aggregation induced by 5-hydroxytryptamine
Hilton, B. P., & Cumings, J. N. (1971) · Journal of Clinical Pathology · doi:10.1136/jcp.24.3.250 · Cited by 69
Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin
Weiss, L. A., Veenstra-VanderWeele, J. M., Newman, D. L., Kim, S., Dytch, H. E., McPeek, M. S., Cheng, S., Ober, C., Cook, E. H., & Abney, M. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201239 · Cited by 68
Inhibition of 5‐hydroxytryptamine2A receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery
Nishihira, K., Yamashita, A., Tanaka, N., Kawamoto, R., Imamura, T., Yamamoto, R., Eto, T., & Asada, Y. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01702.x · Cited by 67
Bioenergetics of serotonin transport by membrane vesicles derived from platelet dense granules.
Fishkes, H., & Rudnick, G. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83830-9 · Cited by 64
PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement
Kastrati, A., Koch, W., Gawaz, M., Mehilli, J., Böttiger, C., Schömig, K., von Beckerath, N., & Schömig, A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00709-9 · Cited by 64
Discussion
Nair, G. V., Gurbel, P. A., O’Connor, C. M., Gattis, W. A., Murugesan, S. R., & Serebruany, V. L. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00284-2 · Cited by 63
Glycoprotein IIIa PlA1/A2 polymorphism and sudden cardiac death
Mikkelsson, J., Perola, M., Laippala, P., Penttilä, A., & Karhunen, P. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00871-8 · Cited by 60
Protein Phosphatase 1 Associates with the Integrin αIIb Subunit and Regulates Signaling
Vijayan, K. V., Liu, Y., Li, T.-T., & Bray, P. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400239200 · Cited by 52
Genetics of Arterial Prothrombotic Risk States
Williams, M. S., & Bray, P. F. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122600504 · Cited by 46
Calcium-Dependent Inhibition of Synaptosomal Serotonin Transport by the α2-Adrenoceptor Agonist 5-Bromo-N-[4,5-dihydro-1 H-imidazol-2-yl]-6-quinoxalinamine (UK14304)
Ansah, T.-A., Ramamoorthy, S., Montañez, S., Daws, L. C., & Blakely, R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047134 · Cited by 41
The Pro33 Isoform of Integrin β3 Enhances Outside-in Signaling in Human Platelets by Regulating the Activation of Serine/Threonine Phosphatases
Vijayan, K. V., Liu, Y., Sun, W., Ito, M., & Bray, P. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500872200 · Cited by 41
The GPIIIa (β3 integrin) PlA polymorphism in the early development of coronary atherosclerosis
Mikkelsson, J., Perola, M., Penttilä, A., Goldschmidt‐Clermont, P. J., & Karhunen, P. J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00683-3 · Cited by 39
Molecular Mechanisms of Prothrombotic Risk Due to Genetic Variations in Platelet Genes: Enhanced Outside-In Signaling Through the Pro 33 Variant of Integrin β 3
Vijayan, K. V., & Bray, P. F. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100504 · Cited by 30
5‐Hydroxytryptamine as a potent migration enhancer of human aortic endothelial cells
Matsusaka, S., & Wakabayashi, I. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.10.068 · Cited by 27

Flagged first, then by citations

Sorted by citations

The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 874
The serotonin system in autism spectrum disorder: From biomarker to animal models
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531
Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior
Veenstra-VanderWeele, J., Muller, C. L., Iwamoto, H., Sauer, J. E., Owens, W. A., Shah, C. R., Cohen, J., Mannangatti, P., Jessen, T., Thompson, B. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112345109 · Cited by 333
Self-citation
Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions
Scotton, W. J., Hill, L. J., Williams, A. C., & Barnes, N. M. (2019) · International Journal of Tryptophan Research · doi:10.1177/1178646919873925 · Cited by 288

See all 180

Authors: Carneiro, A. M. D., Cook, E. H., Murphy, D. L., & Blakely, R. D.
Affiliations: Vanderbilt University (US)
University of Illinois Chicago (US)
National Institutes of Health (US)
Corresponding author: Blakely, Randy D.
ORCID: Carneiro, Ana Marin D.
Cook, Edwin H.
Blakely, Randy D.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2008-04-01
Volume: 118
Issue: 4
Pages: 1544-1552
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci33374
PMC: PMC2260909
OpenAlex: W2144374554
Cited by: 180
References: 50
Citations by year: 2026: 4 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 10 · 2020: 3 · 2019: 13 · 2018: 10 · 2017: 14 · 2016: 9 · 2015: 9 · 2014: 14 · 2013: 13 · 2012: 14
FWCI: 9.36
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Alliance for Research on Schizophrenia and Depression
National Institutes of Health
National Institute of Mental Health (P50MH078028, MH078028, NIMH P50)
National Institute on Drug Abuse (R01DA007390, DA007390)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (U19-HD 35482, U19HD035482)
Topics: Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: serotonin transporter, integrin αIIbβ3, platelet aggregation, serotonin release, vesicular monoamine transporter, fibrinogen, ADP-induced aggregation, thrombin-induced aggregation, hyperserotonemia, autism spectrum disorder, cardiovascular disease
MeSH terms: Alleles, Animals, Biological Transport, Blood Platelets, Cell Line, Cell Membrane, Humans, Platelet Aggregation, Protein Binding, Serotonin, Mice, Knockout, Platelet Glycoprotein GPIIb-IIIa Complex, MAP Kinase Signaling System, p38 Mitogen-Activated Protein Kinases, Serotonin Plasma Membrane Transport Proteins, Mice, Protein Phosphatase 1, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks